The growth drivers in targeted therapeutic areas.

For more information on Ipsen, visit our website at.. About IpsenIpsen is an innovation driven international specialty pharmaceutical company with over 20 products on the market and a worldwide staff of nearly 4th Its development is based on a combination of specialty products, the growth drivers in targeted therapeutic areas , and primary care products which are based a significant contribution to the financing of research activities. More than 700 people in R & D are dedicated to the discovery and development of innovative drugs for patient care. This strategy an active policy an active policy of partnerships.

The active substance in Decapepty is triptorelin, a decapeptide analogue of GnRH , a hormone from the hypothalamus, which initially stimulates the release of pituitary gonadotropins , which in turn control hormonal secretions by secreted the testicles and ovaries. Decapepty will is indicated mainly in the treatment of locally advanced or metastatic prostate cancer. This indication Decapepty temporarily increases the concentration of testosterone and testosterone-dihydro, certain other countries. Administration paradoxically leads to a reduction in plasmatic testosterone concentration. After two to three weeks of treatment testosterone is below the below the castration threshold, thereby depriving prostate tumors of one of the most important hormones to stimulate the development of tumors.At heights and under nitrous oxide narcosis Improvement has lead damage to the retinal vessels and the danger currently remains for several weeks following surgery. According to Dr. Diane Meier, the Principal Investigator of the project The study is the impact of the hospital palliative care services in the quality of cancer patient management. It will also the required necessary to determine which components of of palliative care are wrench key to be valid.

Other entries from category "treatments":

Random entries